Positron Emission Tomography

Positron Emission Tomography has revolutionized oncological imaging, and this survey of the field, part of the respected Methods in Molecular Biology(TM) series, seeks to improve the key channels of communication between the imager and the referring specialist.

Oncological imaging has thoroughly changed in the past decade, especially due to the introduction of PET and 18 FDG. In Positron Emission Tomography , expert referring specialists and professional imagers seek to help bridge some of the knowledge gaps in several oncological domains. The book's goal is to aid in the improvement of communicative competences: to communicate scan findings so that the referring specialist receives proper advice from the imager, and that, alternatively, the referring one provides the imager with appropriate clinical details to allow for a proper interpretation, and that the referring specialist is aware of the possibilities and limitations of the requested technology. While it focuses on FDG PET, other radiopharmaceuticals are covered as well, where appropriate. Written for the highly respected Methods in Molecular Biology™ series, this volume provides the kind of detailed description and implementation advice that is crucial for getting optimal results.

Authoritative and convenient, Positron Emission Tomography serves as an excellent reference for oncologists, surgeons, radiotherapists, radiologists, nuclear medicine physicians, and pathologists desiring a stronger synergy within their vital efforts.

Seeks to improve the vital communication between specialists and imagers Features concrete, practical techniques as written by experts in diagnosis and image interpretation Includes key implementation advice Includes supplementary material: sn.pub/extras

Inhalt

FDG-PET/CT in Lymphoma.- FDG PET Imaging of Head and Neck Cancers.- PET and PET-CT of Lung Cancer.- PET-CT in Radiotherapy for Lung Cancer.- PET and PET-CT in Esophageal and Gastric Cancer.- FDG PET and PET/CT for Colorectal Cancer.- Functional Imaging of Neuroendocrine Tumors.- Melanoma.- Breast Cancer.- Gynecological Cancers.- Sarcoma.- PET and PET/CT in the Management of Thyroid Cancer.- PET in Testicular Cancer.- Pancreatic and Hepatobiliary Cancers.- Prostate Cancer.- Brain Tumors.- PET and PET/CT for Unknown Primary Tumors.- Methodological Aspects of Multi-Centre Studies with Quantitative PET.